NRGSX | SBHCX | NRGSX / SBHCX | |
Total Expense Ratio | 0.74 | 1.14 | 65% |
Annual Report Gross Expense Ratio | 0.74 | 2.46 | 30% |
Fund Existence | 13 years | 6 years | - |
Gain YTD | -3.902 | 1.595 | -245% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.71B | 96.4M | 9,039% |
Annual Yield % from dividends | 0.06 | 0.20 | 32% |
Returns for 1 year | -10.12 | -4.79 | 211% |
Returns for 3 years | 5.90 | 23.66 | 25% |
Returns for 5 years | -2.32 | 21.55 | -11% |
Returns for 10 years | 10.24 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYVYX | 700.65 | 8.79 | +1.27% |
Rydex NASDAQ-100® 2x Strategy H | |||
CCERX | 29.96 | 0.17 | +0.57% |
Columbia Large Cap Enhanced Core R | |||
GMVAX | 16.47 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity A | |||
FCVIX | 19.93 | 0.03 | +0.15% |
Fidelity Advisor Small Cap Value I | |||
CLBAX | 38.93 | 0.05 | +0.13% |
American Funds American Balanced 529A |